You are here: Industry Insights > Novartis

News List

Novartis sells Colorado site to maker of CBD products fiercepharma
June 28, 2019
Novartis and Sandoz already have some experience with the medical marijuana industry, having struck a deal last year to distribute products for a Canadian company that sells medical cannabis products in its home country and in Europe.
Novartis' Gilenya staves off generic challengers⁠—for now⁠—after federal injunction fiercepharma
June 28, 2019
Novartis’ multiple sclerosis med Gilenya is facing U.S. generic challengers on all sides to its blockbuster sales, and the company hoped a court order could stave them off. The Swiss drugmaker got what it asked for—and it might just keep the med at the to
Novartis manufacturing agreement cited in Syria controversy fiercepharma
June 28, 2019
Novartis said that last year it was asked by Swiss State Secretariat for Economic Affairs to obtain the manufacturing documents from MPI showing that the isopropanol had been used to produce Voltaren Emulgel.
US group says Novartis MS drug price out of line with benefit expressbpd
June 27, 2019
The Boston-based Institute for Clinical and Economic Review (ICER), which has been reviewing Mayzent for months, recommended that Novartis lower the drug’s price
Glenmark to partner with Novartis to market three respiratory products in Brazil expressbpd
June 27, 2019
This arrangement will strengthen Glenmark’s respiratory franchise in Brazil Novartis will be responsible to manufacture the products and Glenmark will exclusively commercialize the products in Brazil
Novartis India appoints Sanjay Murdeshwar as Vice Chairman and Managing Director expresspharma
June 21, 2019
Novartis India recently announced the appointment of Sanjay Murdeshwar as Vice Chairman and Managing Director.
Novartis continues to innovate in CML biospectrumasia
June 16, 2019
Novartis International AG / Novartis continues to innovate in CML with long-term treatment-free remission results following Tasigna use and promising combination data with investigational compound asciminib (ABL001).
New Leader of Pharmaceuticals BU for Novartis contractpharma
June 14, 2019
Marie-France Tschudin, an experienced Novartis leader, appointed President of Novartis Pharmaceuticals.
Novartis Presents First-of-its-Kind Histology Data with Iscalimab (CFZ533) Suggesting the Extended Survival of Transplanted Organs May be Possible drugs
June 13, 2019
Novartis Presents First-of-its-Kind Histology Data with Iscalimab (CFZ533) Suggesting the Extended Survival of Transplanted Organs May be Possible.
Novartis’ iscalimab results hint at extended survival of transplanted organs pharmatimes
June 11, 2019
Novartis has presented first-of-its-kind histology data with iscalimab (CFZ533), suggesting that it may be possible to prolong the durability of transplanted kidneys as well as to potentially improve long-term outcomes for kidney transplant patients.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 71 72 Next page